Market Cap (In CNY)
40.91 Billion
Revenue (In CNY)
5.18 Billion
Net Income (In CNY)
1.1 Billion
Avg. Volume
9.11 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 20.166666-27.6
- PE
- -
- EPS
- -
- Beta Value
- 0.365
- ISIN
- CNE000000WF9
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Dao Xing Fu
- Employee Count
- -
- Website
- https://www.tiantanbio.com
- Ipo Date
- 1998-06-16
- Details
- Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; human immunoglobulin; and other blood products. The company was incorporated in 1998 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. operates as a subsidiary of China National Biotec Group Company Limited.
More Stocks
-
STMRF
-
FBLG
-
605388
-
1088
-
603580
-
SCANFLScanfil Oyj
SCANFL
-
TM
-
BOWFF